Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Occupational Therapy Interventions for Adults With Multiple Sclerosis.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Environmental factors and their interactions with risk genotypes in MS susceptibility.
Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen.
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
[Epidemiology of multiple sclerosis].
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis.
The adaptive immune response in celiac disease.
Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.
Enhancing our understanding of white matter changes in early multiple sclerosis.
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.
Considering depression as a consequence of activation of the inflammatory response system.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
Pages
« first
‹ previous
…
717
718
719
720
721
722
723
724
725
…
next ›
last »